New Swab Test for Womb Cancer Approved in the UK

The WID-easy test offers a less invasive alternative for detecting womb cancer, reducing false positives and unnecessary procedures.

The WID-easy test, developed by researchers at University College London and the University of Innsbruck, uses DNA analysis to detect womb cancer from a simple vaginal swab.
The test has been approved by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) for women over 45 with abnormal uterine bleeding.
Compared to traditional methods like transvaginal ultrasounds and hysteroscopies, the swab test is less invasive, reducing patient discomfort and stress.
Studies published in Lancet Oncology show the test is as accurate as ultrasound and cuts false positives by 87%, potentially reducing unnecessary invasive procedures.
Currently available in private clinics, the test may be adopted by the NHS in the future, with advocates highlighting its potential to improve early diagnosis and ease the burden on healthcare systems.